NCT01728246View on ClinicalTrials.gov

An Efficacy, Safety and Effects on Quality of Life of Tramadol/Paracetamol as Add-on Therapy in Chronic Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

473

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Osteoarthritis
Interventions
DRUG

Tramadol/Paracetamol (APAP)

Celecoxib 200 milligram (mg) once daily for 4 weeks and fixed dose combination of Tramadol 37.5 mg/Paracetamol 325 mg thrice daily for 4 weeks as add-on therapy.

DRUG

Non-Tramadol/APAP

Celecoxib 200 mg alone once daily for 4 weeks.

Trial Locations (1)

1700

Janssen Philippines, Paranaque City

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutica

INDUSTRY